Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
Clinical trial NCT02835222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02835222
- Sponsor
- Wake Forest University Health Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-02
- Primary completion
- 2027-02-26
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.